Fujifilm Diosynth Biotechnologies UK Limited

The vast majority of vaccines and biological drugs are manufactured in a batch process as a one off and then divided into smaller units of the supplied medicine. Because there can be differences between batches, and to lower production costs and enhance quality, there is much interest from the drug approval agencies and the drug manufacturers to produce d...

This project seeks to integrate two complementary digital technologies within a continuous manufacturing environment. The fast start project brings together a UK SME (Perceptive Engineering), RTO (CPI, part of the High Value Manufacturing Catapult) and large corporate vendor (Pall Biotech) to incorporate a novel "digital wrapper" automation technology wit...

As biopharma moves to the business mainstream, the industry will increasingly need to find new ways to maintain competitiveness by ensuring affordability, quality, and delivery performance. Continuous processes have been proposed as a solution as they are scalable, offer higher productivity with reduced running times and materials usage, and require small...

The aim of this project is to provide new formulations that bring about a step change in biopharmaceutical yield and quality by improving product stability through the most protein degradation sensitive/impactful areas of downstream processing (DSP). This is a novel approach to improving process efficiency as currently protein products have comparatively ...

Awaiting Public Summary